KATHRYN BROWN: Open Payments
NPI 1104572643 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 31 payments from 13 companies in 2025. Trend: 2023 $2,191 · 2024 $3,086 · 2025 $1,355
Food & beverage: $748Travel & lodging: $607
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $812 |
| Novo Nordisk Inc | 7 | $136 |
| CARDIVA MEDICAL, INC. | 2 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| PFIZER INC. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Boston Scientific Corporation | 1 | $35 |
| Abbott Laboratories | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
Products named: COREVALVE EVOLUT R, Wegovy, SAVVYWIRE, LEQVIO, VYNDAQEL, Kerendia, JARDIANCE, WATCHMAN FLX.
Industry payments across MO — which companies pay providers there.
